Considerations for New Drug Checking Technologies

As drug checking continues to rapidly expand across North America and abroad, companies are eager to get into the federal and opioid settlement funds. In some cases, new technologies are emerging with the goal of improving sensitivity, turnaround time, and accessibility of services. In other cases, existing technologies are being repackaged to be harm reduction facing, without many improvements or appropriate field validation. Given that opioid-facing drug checking itself is a very new field, it can be challenging to navigate the various technologies that are available. This document is intended to assist you in analyzing new drug checking technologies.